Clinical TrialsNanoViricides, Inc. Secures FDA Orphan Designation for NV-387 Measles Thera... NanoViricides, Inc. Secures FDA Orphan Designation for NV-387 Measles Thera... Read Post »
Clinical TrialsBioMarin Highlights VOXZOGO’s Long-Term Benefits on Bone and Growth BioMarin Highlights VOXZOGO’s Long-Term Benefits on Bone and Growth Read Post »
Clinical TrialsAlector Discontinues PROGRESS-AD Trial of Nivisnebart After Futility Analys... Alector Discontinues PROGRESS-AD Trial of Nivisnebart After Futility Analys... Read Post »
New Drug ApprovalFDA Clears VEPPANU, First PROTAC Therapy, for Advanced Breast Cancer FDA Clears VEPPANU, First PROTAC Therapy, for Advanced Breast Cancer Read Post »
New Drug ApprovalMHRA Clears Linerixibat (Lynavoy) for PBC-Related Itch in Adults MHRA Clears Linerixibat (Lynavoy) for PBC-Related Itch in Adults Read Post »
New Drug ApprovalJohnson & Johnson Secures FDA Nod for STELARA in Pediatric Crohn’s Johnson & Johnson Secures FDA Nod for STELARA in Pediatric Crohn’s Read Post »
Drugs Safety AlertMHRA Sets 5-Day Limit on OTC Nasal Decongestant Sprays MHRA Sets 5-Day Limit on OTC Nasal Decongestant Sprays Read Post »
New Drug ApprovalRhythm Wins EU Approval for IMCIVREE in Acquired Hypothalamic Obesity Rhythm Wins EU Approval for IMCIVREE in Acquired Hypothalamic Obesity Read Post »
New Drug ApprovalArrowhead Breaks the Triglyceride Barrier with REDEMPLO Approval in Austral... Arrowhead Breaks the Triglyceride Barrier with REDEMPLO Approval in Austral... Read Post »
Clinical TrialsCorcept Drives Survival Gain in ALS Despite Missing Primary Endpoint Corcept Drives Survival Gain in ALS Despite Missing Primary Endpoint Read Post »
New Drug ApprovalAxsome Wins FDA Decision for Auvelity in Alzheimer’s Agitation Axsome Wins FDA Decision for Auvelity in Alzheimer’s Agitation Read Post »
New Drug ApprovalNorgine Pushes the Frontier of WHIM Treatment With XOLREMDI EU Approval Norgine Pushes the Frontier of WHIM Treatment With XOLREMDI EU Approval Read Post »
Clinical TrialsTelix Advances TLX597-Tx with Positive Phase 2 Dosimetry Findings Telix Advances TLX597-Tx with Positive Phase 2 Dosimetry Findings Read Post »
New Drug ApprovalMitsubishi Tanabe Brings Steady Control to Parkinson’s with EU Nod for On... Mitsubishi Tanabe Brings Steady Control to Parkinson’s with EU Nod for On... Read Post »
Clinical TrialsNovo Nordisk Strikes at the Core of Haemophilia A with Denecimig Breakthrou... Novo Nordisk Strikes at the Core of Haemophilia A with Denecimig Breakthrou... Read Post »
Clinical TrialsNewron Hits a Regulatory Speed Bump as FDA Pauses U.S. Enrollment in ENIGMA... Newron Hits a Regulatory Speed Bump as FDA Pauses U.S. Enrollment in ENIGMA... Read Post »
Clinical TrialsVeradermics Meets Endpoints with Oral VDPHL01 in Pattern Hair Loss Study Veradermics Meets Endpoints with Oral VDPHL01 in Pattern Hair Loss Study Read Post »
Clinical TrialsGilead Leverages Priority Review to Advance Bic/Len in HIV Care Gilead Leverages Priority Review to Advance Bic/Len in HIV Care Read Post »
Clinical TrialsPfizer Sets a New Pace in Multiple Myeloma Treatment with ELREXFIO Pfizer Sets a New Pace in Multiple Myeloma Treatment with ELREXFIO Read Post »
Clinical TrialsImmunome Reports Strong Phase 3 Data, Submits NDA for Varegacestat Immunome Reports Strong Phase 3 Data, Submits NDA for Varegacestat Read Post »
Clinical TrialsFDA Real-Time Trials: AstraZeneca and Amgen Lead Breakthrough FDA Real-Time Trials: AstraZeneca and Amgen Lead Breakthrough Read Post »
New Drug ApprovalAstraZeneca’s Triple-combination inhaler Breztri approved by FDA for asth... AstraZeneca’s Triple-combination inhaler Breztri approved by FDA for asth... Read Post »
Clinical TrialsBoehringer’s survodutide Achieves Up to 16.6% Weight Loss in Phase II... Boehringer’s survodutide Achieves Up to 16.6% Weight Loss in Phase II... Read Post »
Clinical TrialsAbbVie Files Upadacitinib for FDA Approval in Alopecia Areata AbbVie Files Upadacitinib for FDA Approval in Alopecia Areata Read Post »
Clinical TrialsMundipharma Positions REZZAYO as a Steady Shield in Fungal Prevention Study Mundipharma Positions REZZAYO as a Steady Shield in Fungal Prevention Study Read Post »
Clinical TrialsOruka Therapeutics Reports Strong 16-Week Results for ORKA-001 in Psoriasis Oruka Therapeutics Reports Strong 16-Week Results for ORKA-001 in Psoriasis Read Post »
New Drug ApprovalNovartis Targets the Root of CSU With EU Approval of Rhapsido Novartis Targets the Root of CSU With EU Approval of Rhapsido Read Post »
Clinical TrialsIntellia Backs Lonvo-z as One-Time CRISPR Therapy for HAE in Phase 3 HAELO Intellia Backs Lonvo-z as One-Time CRISPR Therapy for HAE in Phase 3 HAELO Read Post »
New Drug ApprovalJohnson & Johnson Gains FDA Nod for CAPLYTA in Schizophrenia Johnson & Johnson Gains FDA Nod for CAPLYTA in Schizophrenia Read Post »
New Drug ApprovalAstraZeneca Clinches FDA Approval for Saphnelo Autoinjector in SLE AstraZeneca Clinches FDA Approval for Saphnelo Autoinjector in SLE Read Post »
Clinical TrialsZydus Takes Zintrodiazine to Phase III After DCGI Clearance in India Zydus Takes Zintrodiazine to Phase III After DCGI Clearance in India Read Post »
New Drug ApprovalCHMP April 2026 Roundup: Breakthroughs in SMA, MS, and Rare Metabolic Disor... CHMP April 2026 Roundup: Breakthroughs in SMA, MS, and Rare Metabolic Disor... Read Post »
Disease & DrugsJohnson & Johnson to Acquire Atraverse Medical, Expanding Cardiac Ablat... Johnson & Johnson to Acquire Atraverse Medical, Expanding Cardiac Ablat... Read Post »
Clinical TrialsKyowa Kirin, Kura Oncology Dose First Patient in Japan Ziftomenib Study Kyowa Kirin, Kura Oncology Dose First Patient in Japan Ziftomenib Study Read Post »
New Drug ApprovalRegeneron Breaks the Silence with Otarmeni, a First-in-Class Hearing Loss G... Regeneron Breaks the Silence with Otarmeni, a First-in-Class Hearing Loss G... Read Post »
Clinical TrialsCatalYm Targets the Root of Cancer-Linked Wasting in VINCIT Trial CatalYm Targets the Root of Cancer-Linked Wasting in VINCIT Trial Read Post »
Clinical TrialsNeurocrine Charts a Lower-Steroid Future for CAH With Crinecerfont Data Neurocrine Charts a Lower-Steroid Future for CAH With Crinecerfont Data Read Post »
Clinical TrialsNovo Nordisk Reports Positive PIONEER TEENS Results for Oral Semaglutide Novo Nordisk Reports Positive PIONEER TEENS Results for Oral Semaglutide Read Post »
Clinical TrialsCapricor Reports Phase 3 HOPE-3 Results for Deramiocel in Duchenne Capricor Reports Phase 3 HOPE-3 Results for Deramiocel in Duchenne Read Post »
Clinical TrialsKyverna Advances Miv-cel with Positive Registrational Data in Rare Neurolog... Kyverna Advances Miv-cel with Positive Registrational Data in Rare Neurolog... Read Post »
New Drug ApprovalDupixent Breaks New Ground in Pediatric Chronic Urticaria Care Dupixent Breaks New Ground in Pediatric Chronic Urticaria Care Read Post »
New Drug ApprovalTzield pushes back the clock on T1D in young children with FDA nod Tzield pushes back the clock on T1D in young children with FDA nod Read Post »
Clinical TrialsNeurona Aims to Break the Cycle of Drug-Resistant MTLE with Rezanecel Neurona Aims to Break the Cycle of Drug-Resistant MTLE with Rezanecel Read Post »
Clinical TrialsJohnson & Johnson Reinforces Disease Control in gMG with Nipocalimab Johnson & Johnson Reinforces Disease Control in gMG with Nipocalimab Read Post »
New Drug ApprovalIpsen Targets Pediatric Glioma in the EU with Landmark Ojemda Approval Ipsen Targets Pediatric Glioma in the EU with Landmark Ojemda Approval Read Post »
Clinical TrialsRoche Advances a New Front in MS Treatment Roche Advances a New Front in MS Treatment Read Post »
Clinical TrialsENSPRYNG Signals a Breakthrough for Roche in MOGAD ENSPRYNG Signals a Breakthrough for Roche in MOGAD Read Post »
New Drug ApprovalMerck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Merck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Read Post »
Clinical TrialsAfter the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path After the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path Read Post »
Clinical TrialsMerck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Merck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Read Post »
